CoQ-10 was first identified in 1957. It is widely used in Japan where millions of Japanese patients receive CoQ-10 as part of their treatment for congestive heart failure.
- SCIENTIFIC NAMES: Mitoquinone; Ubidecarenone; Ubiquinone
- INDICATIONS: Congestive heart failure, angina, diabetes, hypertension, breast cancer, increasing exercise tolerance, muscular dystrophy, chronic fatigue
- SYNONYM: None
- CLASS: Food supplement
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
